$1.68 Billion is the total value of SABBY MANAGEMENT, LLC's 312 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 77.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | SAREPTA THERAPEUTICS INCcall | $34,570,000 | -31.1% | 4,666 | -48.3% | 2.06% | -54.9% | |
| Sell | MERCK & CO INCcall | $27,126,000 | -73.5% | 4,980 | -72.7% | 1.62% | -82.7% | |
| Sell | ALKERMES PLCcall | $7,836,000 | -10.5% | 1,352 | -15.4% | 0.47% | -41.3% | |
| Sell | ALNYLAM PHARMACEUTICALS INCput | $5,956,000 | -70.8% | 500 | -68.8% | 0.36% | -80.8% | |
| Sell | BRISTOL MYERS SQUIBBput | $3,554,000 | -98.3% | 562 | -98.4% | 0.21% | -98.9% | |
| Sell | AMICUS THERAPEUTICS INCcall | $3,024,000 | -79.7% | 2,010 | -80.6% | 0.18% | -86.7% | |
| BMY | Sell | BRISTOL MYERS SQUIBB | $2,948,000 | -94.8% | 46,624 | -95.0% | 0.18% | -96.6% |
| ESPR | Sell | ESPERION THERAPEUTICS INC | $2,722,000 | -70.9% | 37,646 | -73.5% | 0.16% | -81.0% |
| OPGN | Sell | OPGEN INC | $1,750,000 | +729.4% | 1,042,152 | -7.8% | 0.10% | +447.4% |
| APDN | Sell | APPLIED DNA SCIENCES INC | $1,308,000 | -11.7% | 908,762 | -2.5% | 0.08% | -42.2% |
| Sell | MERCK & CO INCput | $1,308,000 | -91.2% | 240 | -91.0% | 0.08% | -94.3% | |
| PRQR | Sell | PROQR THERAPEUTICS N V | $1,058,000 | -5.5% | 344,320 | -0.8% | 0.06% | -38.2% |
| Sell | FIBROGEN INCcall | $1,044,000 | -19.9% | 226 | -17.8% | 0.06% | -47.9% | |
| MNKD | Sell | MANNKIND CORP | $920,000 | -72.6% | 403,816 | -72.1% | 0.06% | -82.0% |
| TRXC | Sell | TRANSENTERIX INC | $872,000 | -36.2% | 513,430 | -27.5% | 0.05% | -58.1% |
| Sell | SANGAMO THERAPEUTICS INCcall | $870,000 | -91.2% | 458 | -92.4% | 0.05% | -94.2% | |
| XENE | Sell | XENON PHARMACEUTICALS INC | $656,000 | -29.5% | 134,000 | -59.3% | 0.04% | -54.1% |
| NSPR | Sell | INSPIREMD INC | $508,000 | -8.5% | 487,588 | -88.7% | 0.03% | -41.2% |
| BPTH | Sell | BIO PATH HOLDINGS INC | $340,000 | -8.4% | 170,026 | -90.7% | 0.02% | -41.2% |
| VTGN | Sell | VISTAGEN THERAPEUTICS INC | $266,000 | -88.7% | 286,972 | -86.4% | 0.02% | -92.5% |
| Sell | TRANSENTERIX INCput | $248,000 | -57.9% | 1,456 | -52.3% | 0.02% | -72.2% | |
| Sell | GALECTIN THERAPEUTICS INCput | $200,000 | -47.1% | 420 | -62.9% | 0.01% | -64.7% | |
| VICL | Sell | VICAL INC. | $174,000 | -65.4% | 119,664 | -56.5% | 0.01% | -78.3% |
| CHEK | Sell | CHECK-CAP LTD | $78,000 | -91.1% | 150,560 | -85.1% | 0.01% | -93.8% |
| BIOC | Sell | BIOCEPT INC | $54,000 | -91.9% | 184,748 | -80.8% | 0.00% | -95.1% |
| Exit | IMMUNOMEDICS INCput | $0 | – | -305 | -100.0% | 0.00% | – | |
| ONSIZ | Exit | ONCOBIOLOGICS INC*w | $0 | – | -199,193 | -100.0% | 0.00% | – |
| KZIA | Exit | KAZIA THERAPEUTICS LTDadr | $0 | – | -366,668 | -100.0% | 0.00% | – |
| ONSIW | Exit | ONCOBIOLOGICS INC*w | $0 | – | -89,644 | -100.0% | 0.00% | – |
| CYTXW | Exit | CYTORI THERAPEUTICS INC*w | $0 | – | -1,028,634 | -100.0% | -0.00% | – |
| IMUCW | Exit | IMMUNOCELLULAR THERAPEUTICS*w | $0 | – | -392,702 | -100.0% | -0.00% | – |
| OASMY | Exit | OASMIA PHARMACEUTICALadr | $0 | – | -19,000 | -100.0% | -0.00% | – |
| Exit | MANNKIND CORPcall | $0 | – | -116 | -100.0% | -0.00% | – | |
| Exit | AETERNA ZENTARIS INCcall | $0 | – | -138 | -100.0% | -0.00% | – | |
| Exit | AGENUS INCput | $0 | – | -116 | -100.0% | -0.00% | – | |
| CFRX | Exit | CONTRAFECT CORP. | $0 | – | -34,333 | -100.0% | -0.00% | – |
| BNTCW | Exit | BENITEC BIOPHARMA LTD*w | $0 | – | -90,193 | -100.0% | -0.00% | – |
| IMMP | Exit | IMMUTEP LTDadr | $0 | – | -21,500 | -100.0% | -0.00% | – |
| ACHN | Exit | ACHILLION PHARMACEUTICALS INC | $0 | – | -16,705 | -100.0% | -0.00% | – |
| Exit | AETERNA ZENTARIS INCput | $0 | – | -264 | -100.0% | -0.00% | – | |
| Exit | ACHILLION PHARMACEUTICALS INCput | $0 | – | -174 | -100.0% | -0.01% | – | |
| Exit | NABRIVA THERAPEUTICS PLC | $0 | – | -10,000 | -100.0% | -0.01% | – | |
| TNDM | Exit | TANDEM DIABETES CARE INC. | $0 | – | -27,487 | -100.0% | -0.01% | – |
| EGLTQ | Exit | EGALET CORP | $0 | – | -73,792 | -100.0% | -0.01% | – |
| Exit | ADVAXIS INCcall | $0 | – | -270 | -100.0% | -0.01% | – | |
| RDHL | Exit | REDHILL BIOPHARMA LTDads | $0 | – | -21,322 | -100.0% | -0.01% | – |
| Exit | ANTHERA PHARMACEUTICALS INCput | $0 | – | -658 | -100.0% | -0.01% | – | |
| RTTR | Exit | RITTER PHARMACEUTICALS INC | $0 | – | -357,781 | -100.0% | -0.01% | – |
| SPHS | Exit | SOPHIRIS BIO INC | $0 | – | -55,907 | -100.0% | -0.01% | – |
| JAGX | Exit | JAGUAR HEALTH INC | $0 | – | -1,045,741 | -100.0% | -0.01% | – |
| ABIO | Exit | ARCA BIOPHARMA INC | $0 | – | -100,000 | -100.0% | -0.01% | – |
| Exit | GALENA BIOPHARMA INCcall | $0 | – | -7,602 | -100.0% | -0.02% | – | |
| AIMT | Exit | AIMMUNE THERAPEUTICS INC | $0 | – | -5,629 | -100.0% | -0.02% | – |
| ONCS | Exit | ONCOSEC MEDICAL INC | $0 | – | -153,137 | -100.0% | -0.02% | – |
| Exit | REGENXBIO INCcall | $0 | – | -81 | -100.0% | -0.02% | – | |
| VTVT | Exit | VTV THERAPEUTICS INCcl a | $0 | – | -44,500 | -100.0% | -0.02% | – |
| RXIIW | Exit | RXI PHARMACEUTICALS CORP*w | $0 | – | -2,100,797 | -100.0% | -0.02% | – |
| Exit | ACHILLION PHARMACEUTICALS INCcall | $0 | – | -992 | -100.0% | -0.03% | – | |
| PTI | Exit | PROTEOSTASIS THERAPEUTICS INC | $0 | – | -60,000 | -100.0% | -0.03% | – |
| YTEN | Exit | YIELD10 BIOSCIENCE INC | $0 | – | -215,250 | -100.0% | -0.04% | – |
| Exit | CLOVIS ONCOLOGY INCcall | $0 | – | -67 | -100.0% | -0.04% | – | |
| SNSS | Exit | SUNESIS PHARMACEUTICALS INC | $0 | – | -125,000 | -100.0% | -0.04% | – |
| LPTX | Exit | LEAP THERAPEUTICS INC | $0 | – | -89,350 | -100.0% | -0.05% | – |
| AXGT | Exit | AXOVANT SCIENCES LTD | $0 | – | -115,462 | -100.0% | -0.06% | – |
| IDRA | Exit | IDERA PHARMACEUTICALS INC | $0 | – | -307,987 | -100.0% | -0.06% | – |
| GALE | Exit | GALENA BIOPHARMA INC | $0 | – | -2,623,610 | -100.0% | -0.06% | – |
| Exit | TESARO INCcall | $0 | – | -85 | -100.0% | -0.06% | – | |
| Exit | AMAG PHARMACEUTICALS INCcall | $0 | – | -553 | -100.0% | -0.07% | – | |
| BPMX | Exit | BIOPHARMX CORP | $0 | – | -6,713,756 | -100.0% | -0.07% | – |
| FCSC | Exit | FIBROCELL SCIENCE INC | $0 | – | -1,128,588 | -100.0% | -0.07% | – |
| CPST | Exit | CAPSTONE TURBINE CORP. | $0 | – | -983,787 | -100.0% | -0.07% | – |
| TSRO | Exit | TESARO INC | $0 | – | -9,700 | -100.0% | -0.07% | – |
| Exit | AIMMUNE THERAPEUTICS INCput | $0 | – | -222 | -100.0% | -0.08% | – | |
| Exit | TESARO INCput | $0 | – | -104 | -100.0% | -0.08% | – | |
| IPCI | Exit | INTELLIPHARMACEUTICS INTERNATIONAL INC | $0 | – | -1,083,637 | -100.0% | -0.08% | – |
| Exit | AGENUS INCcall | $0 | – | -2,860 | -100.0% | -0.08% | – | |
| Exit | AXOVANT SCIENCES LTDput | $0 | – | -1,848 | -100.0% | -0.09% | – | |
| HTBX | Exit | HEAT BIOLOGICS INC | $0 | – | -2,615,123 | -100.0% | -0.09% | – |
| Exit | AXOVANT SCIENCES LTDcall | $0 | – | -2,146 | -100.0% | -0.10% | – | |
| DERM | Exit | DERMIRA INC | $0 | – | -45,304 | -100.0% | -0.12% | – |
| AMAG | Exit | AMAG PHARMACEUTICALS INC | $0 | – | -118,864 | -100.0% | -0.14% | – |
| Exit | MANNKIND CORPput | $0 | – | -8,169 | -100.0% | -0.17% | – | |
| HSGX | Exit | HISTOGENICS CORP. | $0 | – | -955,060 | -100.0% | -0.18% | – |
| Exit | DERMIRA INCput | $0 | – | -766 | -100.0% | -0.19% | – | |
| Exit | AMAG PHARMACEUTICALS INCput | $0 | – | -1,822 | -100.0% | -0.22% | – | |
| Exit | INTERCEPT PHARMACEUTICALS INCcall | $0 | – | -447 | -100.0% | -0.24% | – | |
| ABBV | Exit | ABBVIE INC | $0 | – | -27,559 | -100.0% | -0.24% | – |
| Exit | GILEAD SCIENCES INCcall | $0 | – | -454 | -100.0% | -0.30% | – | |
| Exit | SAGE THERAPEUTICS INCput | $0 | – | -259 | -100.0% | -0.39% | – | |
| Exit | GW PHARMACEUTICALS PLCput | $0 | – | -353 | -100.0% | -0.42% | – | |
| Exit | RADIUS HEALTH INCcall | $0 | – | -1,536 | -100.0% | -0.44% | – | |
| Exit | SPDR S&P BIOTECHcall | $0 | – | -656 | -100.0% | -0.51% | – | |
| ONCE | Exit | SPARK THERAPEUTICS INC | $0 | – | -110,827 | -100.0% | -0.52% | – |
| Exit | SAGE THERAPEUTICS INCcall | $0 | – | -350 | -100.0% | -0.52% | – | |
| Exit | IONIS PHARMACEUTICALS INCput | $0 | – | -1,230 | -100.0% | -0.56% | – | |
| Exit | IONIS PHARMACEUTICALS INCcall | $0 | – | -1,429 | -100.0% | -0.66% | – | |
| Exit | VERTEX PHARMACEUTICALS INCput | $0 | – | -486 | -100.0% | -0.66% | – | |
| Exit | ABBVIE INCput | $0 | – | -776 | -100.0% | -0.68% | – | |
| Exit | BLUEBIRD BIO INCput | $0 | – | -485 | -100.0% | -0.79% | – | |
| Exit | HALOZYME THERAPEUTICS INCcall | $0 | – | -4,950 | -100.0% | -0.91% | – | |
| Exit | ALNYLAM PHARMACEUTICALS INCcall | $0 | – | -941 | -100.0% | -1.09% | – | |
| Exit | CIGNA CORPcall | $0 | – | -670 | -100.0% | -1.24% | – | |
| Exit | JUNO THERAPEUTICS INCcall | $0 | – | -3,003 | -100.0% | -1.25% | – | |
| Exit | BRISTOL MYERS SQUIBB COcall | $0 | – | -4,225 | -100.0% | -2.36% | – | |
| Exit | SPDR S&P 500call | $0 | – | -3,000 | -100.0% | -4.88% | – | |
| Exit | BLUEBIRD BIO INCcall | $0 | – | -4,250 | -100.0% | -6.89% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
| ISHARES TR | 35 | Q3 2023 | 52.2% |
| SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
| AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
| BIOGEN INC | 24 | Q1 2021 | 26.2% |
| SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
| BIOGEN INC | 23 | Q1 2021 | 13.7% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
| BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
| VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
| Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
| Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
| Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
| HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
| PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
| Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
| TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
| Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
| TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.